Seeking Alpha

Salix Pharmaceutica (SLXP -0.3%) gets a Paragraph VI Patent certification for its ulcerative...

Salix Pharmaceutica (SLXP -0.3%) gets a Paragraph VI Patent certification for its ulcerative colitis treatment Apriso.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|